Chemical Component Separation with Botox


Clinical Anatomy

  • Comprehensive knowledge of the lateral abdominal wall muscles is required to understand the function of these muscles and to ensure adequate coverage with botulinum toxin (BTX).

  • External oblique fibers run inferomedially to provide lateral flexion and rotation.

  • Internal oblique fibers run superomedially, directly perpendicular to the external oblique fibers, to provide abduction and rotation.

  • Transversus abdominis fibers run medially to laterally to provide pelvic and lower back stabilization.

  • These muscles produce tension on midline hernia repairs in the direction of their fibers. In addition, they are considered accessory muscles of breathing.

  • BTX type A (Botox; Allergan, Irvine, CA), as a neuromodulating agent, blocks the release of acetylcholine and other pain-modulating substances to produce flaccid paralysis ( Fig. 12.1 ).

    Fig. 12.1

  • The maximum effect of BTX is reached at approximately 3 weeks, providing a benefit for 3-6 months after the procedure.

Preoperative Considerations

Patient Selection

  • There are currently four indications for BTX injections of the lateral abdominal wall.

    • Planned abdominal wall reconstruction in the setting of a large ventral hernia

    • Preoperative or postoperative pain secondary to lateral abdominal wall muscle spasms

    • Open abdomen after damage control laparotomy

    • Massive intrathoracic herniation of abdominal contents

  • Severe chronic obstructive pulmonary disease is a relative contraindication to chemical component separation because of the flaccidity of accessory breathing muscles.

  • Contraindications to BTX include preexisting pareses (amyotrophic lateral sclerosis, myopathies, motor polyneuropathies), impaired neuromuscular transmission (myasthenia gravis, Lambert-Eaton syndrome), and concurrent aminoglycoside use.

  • Although the planned abdominal wall reconstruction is a major operative intervention, BTX injections are an outpatient procedure with minimal physiologic sequelae. If a patient is optimized for the major procedure, no further preoperative optimization except for consideration of anticoagulation cessation is required.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here